Exploring the Polyethylene Glycol-Modified Drug Patent Landscape by Deep Learning
Therapeutic Innovation & Regulatory Science · 2026-11 · 60 (6) · 1874-1888
DOI: 10.1007/s43441-026-01032-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Therapeutic Innovation & Regulatory Science, online erschienen am 13.08.2026. Verfasst von Tingting Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Artificial Intelligence, Qingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao…. Hauptthemen laut MEDLINE: Polyethylene Glycols, Deep Learning, Patents as Topic. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Scientific Research Fund Project of Shandong University of Chinese Medicine, Natural Science Foundation of Shandong Province.
Abstract (Originalsprache)
OBJECTIVE: Recently, polyethylene glycol modification has become key to improving biopharmaceutical pharmacokinetics and clinical applicability. This study aims to build a comprehensive analytical framework that integrates current status analysis, technology flow, and value assessment, in order to provide a step-by-step and thorough characterization of the patent landscape for PEG-modified drugs. METHODS: Using the Derwent patent database, this study compiled 99,540 PEG-related patents worldwide from 2014 to 2023. Descriptive statistics, social network analysis, machine learning, and deep learning methods were applied to analyze these patents. RESULTS: The number of related patents increased dramatically over the past decade. China filed the most patents (24303) but exhibited a narrower technological breadth, while the United States led in numbers of inventors (86208) and assignees (37045). Patents from developed regions are more likely to be cited, and patent transfer activities mainly occur between commercial institutions. PEG-modified proteins and peptides represent the most commercially active category, highlighting their current market relevance. For patent transfer prediction, the XGBoost model achieved an average accuracy of 88.15%, an average F1-score of 88.28%, and a test ROC-AUC of 87.00%. For early-stage patent quality assessment, the RoBERTa-BiLSTM-MLP model achieved an accuracy of 65.95% and an F1-score of 64.53%. CONCLUSION: These analyses provide a multi-layered understanding of the PEG-modified drug patent landscape, from static features to dynamic trends and from quantitative indicators to qualitative evaluations. These findings provide an analytical reference for exploring technology trends in the field of PEG-modified drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Medical Artificial Intelligence, Qingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, 266112, Qingdao, China.
- Center for Medical Artificial Intelligence, Shandong University of Traditional Chinese Medicine, Qingdao, 266112, China.
- Qingdao Key Laboratory of Artificial Intelligence Technology for Chinese Medicine, Qingdao, 266112, China.
- Department of Cardiovascular Surgery, The Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau, 999078, China.
- Center for Medical Artificial Intelligence, Qingdao Academy of Chinese Medical Sciences, Shandong University of Traditional Chinese Medicine, Qingdao, 266112, Qingdao, China. liukunmeng@sdutcm.edu.cn.
Förderung
- National Natural Science Foundation of China
- Scientific Research Fund Project of Shandong University of Chinese Medicine
- Natural Science Foundation of Shandong Province
Zitieren
APA
Zhang, T., Deng, D., Zhang, X., Chen, W., Wang, P., Li, X., Cong, J., Wei, B., & Liu, K. (2026). Exploring the Polyethylene Glycol-Modified Drug Patent Landscape by Deep Learning. Therapeutic Innovation & Regulatory Science, 60(6), 1874-1888. https://doi.org/10.1007/s43441-026-01032-9
Vancouver
Zhang T, Deng D, Zhang X, Chen W, Wang P, Li X, et al. Exploring the Polyethylene Glycol-Modified Drug Patent Landscape by Deep Learning. Therapeutic Innovation & Regulatory Science. 2026;60(6):1874-1888. doi:10.1007/s43441-026-01032-9
BibTeX
@article{Zhang2026,
author = {Zhang, Tingting and Deng, Dechao and Zhang, Xiaoming and Chen, Weijie and Wang, Pingping and Li, Xiang and Cong, Jinyu and Wei, Benzheng and Liu, Kunmeng},
title = {Exploring the Polyethylene Glycol-Modified Drug Patent Landscape by Deep Learning},
journal = {Therapeutic Innovation & Regulatory Science},
year = {2026},
volume = {60},
number = {6},
pages = {1874--1888},
doi = {10.1007/s43441-026-01032-9}
}
EUVIMED